Terbinafine-induced hepatotoxicity
Gastroenterol Hepatol. 2019 Jun-Jul;42(6):394-395.
doi: 10.1016/j.gastrohep.2018.05.022.
Epub 2018 Jul 6.
[Article in
English,
Spanish]
Affiliations
- 1 Unidad de Gestión Clínica de Aparato Digestivo, Hospitales Universitarios Virgen del Rocío, Sevilla, España. Electronic address: [email protected].
- 2 Unidad de Gestión Clínica de Aparato Digestivo, Hospitales Universitarios Virgen del Rocío, Sevilla, España.
No abstract available
MeSH terms
-
Antifungal Agents / adverse effects*
-
Antifungal Agents / therapeutic use
-
Chemical and Drug Induced Liver Injury / blood
-
Chemical and Drug Induced Liver Injury / etiology*
-
Cholestasis, Intrahepatic / blood
-
Cholestasis, Intrahepatic / chemically induced
-
Cholestasis, Intrahepatic / drug therapy
-
Female
-
Humans
-
Middle Aged
-
Onychomycosis / complications
-
Onychomycosis / drug therapy
-
Spondylitis, Ankylosing / complications
-
Terbinafine / adverse effects*
-
Terbinafine / therapeutic use
-
Ursodeoxycholic Acid / therapeutic use
Substances
-
Antifungal Agents
-
Ursodeoxycholic Acid
-
Terbinafine